Article
Mechanisms of CHD5 Inactivation in Neuroblastomas
1 Feb 2012
Abstract excerpt
PURPOSE: Neuroblastomas (NBs) have genomic, biological, and clinical heterogeneity. High-risk NBs are characterized by several genomic changes, including MYCN amplification and 1p36 deletion. We identified the chromatin-remodeling gene CHD5 as a tumor suppressor gene that maps to 1p36.31. Low or absent CHD5 expression is associated with a 1p36 deletion and an unfavorable outcome, but the mechanisms of CHD5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
